News

Video

Key Decision Factors in Selecting Frontline Therapy for Metastatic RCC

Related Videos
Alan Tan, MD, Vanderbilt-Ingram Cancer Center
5 KOLs are featured in this series.
5 KOLs are featured in this series.
Chad Tang, MD
5 KOLs are featured in this series.
Martin H. Voss, MD